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Abstract

Representative Syntheses of Fungal Inhibitor Candidates
Synthesis of compounds which match our general design (Fig. 4) begins by
attaching synthesizing a folate mimic and then adding a “linker” group (Fig. 6).3

By using methods similar to those shown in Figures 6-10, a number of similar
potential inhibitors have been synthesized (Fig. 11). This library of molecules
provides a number of subtle structural differences. The hope is that these small
changes will help identify a molecule that has the perfect “fit” in the enzyme.

Future Work
As the MetSyn enzyme converts homocysteine to methionine (Fig. 1), a simple
method for monitoring MetSyn activity would be optical detection of
homocysteine concentration. The MeasureIT-thiol quantification assay gives a
fluorescent response which can be used to generate a calibration curve of
homocysteine levels (Fig. 16).5
Fluorescence Intensity

Methionine Synthase (MetSyn) is an enzyme that uses folate and
homocysteine to create the amino acid methionine, which is essential for all
organisms. There are key differences between the fungal MetSyn enzyme and
the mammalian (human) form, especially with regard to the proximity of the
two binding sites for folate and homocysteine. Taking advantage of these
differences, an antifungal drug could be developed to exclusively bind the
fungal enzyme and inhibit fungal growth while leaving the host (patient)
unaffected. We are currently exploring the synthesis of various molecules that
mimic folate, an essential substrate for MetSyn function. We plan to screen
these molecules against various fungal species as well as in an isolated system
with the MetSyn enzyme itself.

Inhibitor Candidates
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Background
Fungal infections are a common public health concern especially in regards to
immunocompromised patients who are at a greater risk of death in such cases.1
As there is an increase of drug resistant fungi, there is a need for new types of
anti-fungal drugs. Methionine Synthase (MetSyn), an enzyme which converts
homocysteine (Hcy) to methionine using a substituted folate molecule (Fig. 1),
could provide a potential pathway for safe antifungal treatment.

Figure 1: Net reaction of MetSyn

The structure of MetSyn used by fungi
is
different than that used by
mammals.2 In the fungal enzyme,
folate and homocysteine bind to two
pockets that are close together (Fig. 2).
In humans, the folate and Hcy bind
pockets are very far apart. This makes
it possible to design synthetic
compounds
which
could
simultaneously bind the folate and
homocysteine pockets in the fungal
enzyme, while being unable to
competitively bind the mammalian
MetSyn form (Fig. 3).

Figure 2: In fungal MetSyn, folate
and Hcy bind in close proximity.

Therefore, compounds designed to
inhibit fungal MetSyn could serve as
antifungal drugs which should not
affect the biochemistry of the patient.

Figure 6: A deazaguanine was synthesized, which can mimic folate. This was then coupled
to a furan linker

As an alternative to the synthesis above, 8-mercaptoguanine was made and
alkylated with a version of the furan linker (Fig. 7). This has the benefit of
being a shorter synthesis, while also introducing diversity in the structure.

Using the modeling program
AutoDock, we can virtually screen
potential molecules to confirm they
can reach both binding sites (Fig. 5).

Figure 11: Current library of compounds to be tested

Figure 7: Alternative structure, which still contains a folate mimic and linker

These two molecules would then need to be attached to a Hcy mimic. The
synthesis of this “amino acid tail” is done starting from asparagine (Fig 8).4
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Another unique aspect about fungal MetSyn, compared to the mammalian
enzyme, is that it requires a poly-glutamated folate substrate, while the
mammalian enzyme can function with folate containing only one glutamate.2
Therefore, we can also
model our folate mimic to
closely resemble 5-methyltetrahydrofolate-diGlutamate
(Fig. 12), as this would more
selectively target fungal Figure 12: 5-Me-Tetrahydrofolate-diGlutamate;
a natural substrate of fungal MetSyn
MetSyn.
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To make a molecule which more closely resembles this version of folate, a
diglutamate must be synthesized (Fig. 13).
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This was adapted to observe the MetSyn enzyme reaction (Fig. 17). As expected,
the enzyme alone gives little fluorescence, but Hcy results in a high fluorescent
response. When the enzyme in functioning, the Hcy is consumed, and the
fluorescence is lower.

Figure 17: Monitoring MetSyn activity by fluorescent detection of Hcy levels

The next step would be to expose MetSyn to our compounds. A successful
inhibitor would results in significant homocysteine left over, giving a “turn-on”
fluorescence response to indicate inhibition.
We are also in the process of screening our compounds against microorganisms
with the help of Dr. Nunnelly in the biology department.
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With the protected amino acid tail in hand, this was coupled to one of the
folate mimics baring a linker (Fig. 9). The protecting groups ensured that only
one possible amide bond could form in the coupling reaction.
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Figure 13: Synthesis of a di-glutamate, linked at the side-chain carboxylic acid
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This was then linked onto one of our folate mimics (Fig. 14), and the benzyl
esters removed (Fig. 15) to give the final product. .
Figure 9: Amide bond coupling of protected amino acid tail to an extended folate mimic

To complete the synthesis of the designed inhibitor candidate, the protecting
groups were removed under acidic conditions (Fig. 10).

Figure 10: Deprotection step to provide the final product
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Figure 14: Synthesis of a di-glutamate, linked at the side-chain carboxylic acid

Figure 4: Generalized Inhibitor Molecule

Figure 5: Computer Modeling of potential molecules binding within the enzyme
binding pockets.
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Alternative Folate-mimic Strategy

General Design of Molecules
A molecule specific for fungal MetSyn would need a folate mimic attached to
a Hcy mimic by some short linker (Fig. 4). This should properly fit in the
fungal enzyme, because the two binding pockets are so close together.
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Figure 16: Fluorescent detection of Homocysteine concentration.

Figure 8: Synthesis of the protected amino acid tail to mimic Hcy

Figure 3: Cartoon model for a molecule
binding fungal MetSyn, but it cannot fit
inside human MetSyn.
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Figure 15: Removal of benzyl esters to provide a di-glutamated folate mimic
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